학술논문

Combination immunotherapy for pancreatic cancer: challenges and future considerations.
Document Type
Article
Source
Expert Review of Clinical Immunology; Nov2022, Vol. 18 Issue 11, p1173-1186, 14p
Subject
PANCREATIC cancer
MYELOID-derived suppressor cells
IMMUNE checkpoint inhibitors
CANCER chemotherapy
IMMUNOTHERAPY
Language
ISSN
1744666X
Abstract
Copyright of Expert Review of Clinical Immunology is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)